The risk of PD-L1 expression misclassification in triple-negative breast cancer. Ben Dori S, Aizic A, Zubkov A, Tsuriel S, et al. Breast Cancer Res Treat 2022 May 27. pii: 10.1007/s10549-022-06630.

Read + Share

Amedeo Smart

Independent Medical Education

Ben Dori S, Aizic A, Zubkov A, Tsuriel S, et al. The risk of PD-L1 expression misclassification in triple-negative breast cancer. Breast Cancer Res Treat 2022 May 27. pii: 10.1007/s10549-022-06630.
PMID: 35622241